Skin Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Skin Cancer Information Center has current, evidence-based information for you. Get the facts about skin cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing skin cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—join us in our safe and private online community for support and inspiration, and share your experience with thousands of other individuals who have been affected by skin cancer. Join the discussion now to share your story and to learn how others like you have dealt with diagnosis, treatment decisions, side effects, living with metastatic disease, caregiving, and survivorship. Login or register here.
People who follow the diet and lifestyle recommendations laid out by the WCRF and the AICR have a 20 percent reduced risk of dying from cancer. Cancer Deaths on the Decline
Overall cancer death rates are declining and cancer incidence has decreased in men and stabilized in women. Coffee Might Reduce the Risk of Basal Cell Carcinoma
Increased intake of caffeinated coffee is associated with a decreased risk of basal cell carcinoma.
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide... Anemia: A Manageable Side Effect Skin Cancer
Anemia, one of the most common side effects associated with cancer, affects over...
Skin Cancer Management
By Diana Price When Dr. Perry Robbins founded the Skin Cancer Foundation in 1979,... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Skin Cancer Clinical Trials
REFMAL31 – A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
REFMAL32 – AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
REFMAL33 – A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS